[{"Assets_0_Q1_USD":12854800000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":897000000.0,"NetIncomeLossConverted_1_Q1_USD":461100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":115500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":108900000.0,"StockholdersEquity_0_Q1_USD":9444700000.0,"EarningsPerShareBasic_1_Q1_USD":4.23,"EarningsPerShareDiluted_1_Q1_USD":3.99,"RevenuesConverted_1_Q1_USD":1711800000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190507"}]